299 filings
Page 8 of 15
8-K
fb0eua8xda0glfyo3
18 Oct 18
Verastem Oncology Announces Executive Leadership Appointments and Changes
4:12pm
8-K
jgpvfw w8w2k2
17 Oct 18
Entry into a Material Definitive Agreement
5:18pm
8-K
234uy4dl w99
17 Oct 18
Other Events
8:02am
424B5
kuumac ytx
12 Oct 18
Prospectus supplement for primary offering
5:24pm
FWP
l8vld9qk1mh2
12 Oct 18
Free writing prospectus
12:00am
424B5
bivgz1x lhyzzrk
11 Oct 18
Prospectus supplement for primary offering
4:55pm
8-K
rovjuri03f y443oole
11 Oct 18
Entry into a Material Definitive Agreement
4:34pm
8-K
9lfto
25 Sep 18
Entry into a Material Definitive Agreement
4:40pm
8-K
abbekar2sidv wn8lv5
24 Sep 18
Verastem Oncology Receives FDA Approval of COPIKTRA™ (duvelisib) capsules
4:59pm
CT ORDER
cezy89oh
18 Sep 18
Confidential treatment order
12:00am
8-K
66xq3y16 l4w
29 Aug 18
Verastem Oncology Appoints Robert E. Gagnon as Chief Financial Officer
12:00am
EFFECT
7pipb c65ypwt
6 Aug 18
Notice of effectiveness
12:15am
CORRESP
j70xo354p
1 Aug 18
Correspondence with SEC
12:00am
UPLOAD
s0ebq1l0olt 2zv
31 Jul 18
Letter from SEC
12:00am
8-K
ojbg197 1pkxx9p
28 Jun 18
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:28pm
8-K
qmpe7e0c
15 Jun 18
Other Events
12:00am
S-3MEF
mz1263 6wl
14 Jun 18
Registration of additional securities for an S-3
12:00am